Gsk Share Discussion Threads

[action] 15/9/2017 11:06

I do not understand why this one voing down even after brokers r upgrade

[action] 15/9/2017 11:03

Tim3 what is 15 month low pls?

[montyhedge] 15/9/2017 10:33

romeike
No they are not bonds, but when you know what dividend you will get every year, I can tell you all being well the GSK dividend in two years will be 80p.
Its like a bond I said. Ord shares dividends should go up not stay the same for years.

NY Boy
1385p. If the pound strengthens.

[ny boy] 15/9/2017 10:27

Lol Monty what price you looking for to get back in?

[tim 3] 15/9/2017 10:26

If 1460 support goes we are looking at 15 month lows,good value imo.

[romeike] 15/9/2017 10:12

Monty - again a totally idiotic statement. You really are special.

GSK shares are patently not bonds.

[montyhedge] 15/9/2017 09:21

Trouble is this share is really a bond with double the risk, GSK Corporate bond about 4%.
Ord share roughly 5% dividend, pays 80p every year, never goes up or down so to me a bond.
But could be cut, corporate bond price stays the same and virtually guarantee.

[marine boy] 15/9/2017 08:38

Expecting a blue finish today.

[essentialinvestor] 15/9/2017 08:22

Hoped for lower this m9rning.

[tradermichael] 15/9/2017 08:18

Regulatory applications have been submitted and are undergoing assessment in a number of other countries, including the US, Australia and Canada. FF/UMEC/VI is an investigational medicine not yet approved for use as a single inhaler triple therapy anywhere in the world. The proposed trade name ‘Trelegy Ellipta’ is subject to regulatory approval.

[tradermichael] 15/9/2017 08:17

Positive newsflow will 0vertake currency exchamge variations:



GlaxoSmithKline (LSE:GSK)
Intraday Stock Chart

Today : Friday 15 September 2017

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for fluticasone furoate/ umeclidinium/vilanterol (FF/UMEC/VI) as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptom control see section 5.1). The proposed brand name is Trelegy Ellipta.

[montyhedge] 15/9/2017 08:04

1395p possible if £ continues strong.

[montyhedge] 15/9/2017 08:03

Sterling of course took dollar earners up, now to take them back down. £ stronger.

[montyhedge] 14/9/2017 19:48

One thing when I had my shingles vac last week, the doctor said it's a live vaccination, I noticed GSK is not live.I don't know the difference.

[montyhedge] 14/9/2017 19:44

Ny BoyNever given a tick up or down ever on Advfn. Can't see the point.

[romeike] 14/9/2017 15:41

Yes supposedly all these dirty banks are now a fantastic buy because interest rates might go up 0.25 sometime in the next two years

[essentialinvestor] 14/9/2017 15:40

May be an opportunity tomorrow.

[philanderer] 14/9/2017 13:40

14th sept HSBC buy tp 2000p up from 1970p

[romeike] 14/9/2017 11:43

To be clear, final approval should be soon, technically FDA can ignore its own biologics advisory team's recommendation but I can't remember that ever happening. And just to reiterate, the recommendation was unanimous.

[ny boy] 14/9/2017 10:10

No the actual FDA approval should follow in a few weeks, I'm in no rush but took the opportunity to top up yesterday.

Something nice to look forward to here, apart from the divi!

[tompion] 14/9/2017 10:07

I think the market was expecting approval - thus no response.

[ny boy] 14/9/2017 09:48

Don't worry about Monty, he is quite harmless &usually misses the move, his main claim to fame is giving me a red thumbs down for each of my posts.. watch this one receive one soon lol!

[spcecks] 14/9/2017 09:46

Good news.

[jadeticl3] 14/9/2017 09:29

Maybe the Market is full of Montys!!!

[philanderer] 14/9/2017 09:24

Market well impressed ;-)